Pharmaceutical News and Articles
Comprehensive and up-to-date drug news for both consumers and healthcare professionals.
ED Visit Rate 36.1 per 1,000 Older Adults With Alzheimer Disease
TUESDAY, Oct. 29, 2024 -- For adults aged 65 years and older with Alzheimer disease, the emergency department visit rate was 36.1 visits per 1,000 adults in...
Female Pediatricians Earn About 93 Percent of Male Pediatricians
TUESDAY, Oct. 29, 2024 -- Female pediatricians earn about 93 percent of what male pediatricians earn, according to a study published online Oct. 29 in...
Healthy Eating Index 2015 Score Linked to Overactive Bladder
TUESDAY, Oct. 29, 2024 -- There is a positive association between a higher Healthy Eating Index (HEI)-2015 score and overactive bladder (OAB), according to a...
Many Seniors at Risk for Financial Precarity From Cost of Hospital Stay
TUESDAY, Oct. 29, 2024 -- Many Medicare beneficiaries are at risk for financial hardship from the costs of a single hospital stay, according to a study...
Abeona Therapeutics Completes Pz-cel Biologics License Application Resubmission to U.S. Food and Drug Administration
CLEVELAND, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that the Company has resubmitted its Biologics License...
Clinicians Often Fail to Rescue Women With Complications After High-Risk Surgery
TUESDAY, Oct. 29, 2024 -- Clinicians fail to rescue female patients with complications after high-risk vascular and cardiac surgeries more often than male...
How AI Might Help Men Fighting Prostate Cancer
TUESDAY, Oct. 29, 2024 -- Artificial intelligence might be able to help doctors detect the prostate cancers most likely to be life-threatening to men, a new...
Iowa Resident Dies of Suspected Lassa Fever After Trip to West Africa
TUESDAY, Oct. 29, 2024 -- Health officials are investigating the case of an Iowa resident who died of Lassa fever after traveling recently to West Africa. The...
AI Might Help Pick Up Heart Trouble in Dogs
TUESDAY, Oct. 29, 2024 -- Artificial intelligence can accurately detect heart murmurs in dogs, a new study finds. The AI program detects heart murmurs in...
Childhood Attention Issues Show Links to Later Risk for Psychosis, Schizophrenia
TUESDAY, Oct. 29, 2024 -- Most kids with attention issues won't go on to develop serious psychiatric conditions like psychosis or schizophrenia. However, a...
Colonoscopy Still Beats New Blood Tests at Spotting Colon Cancer
TUESDAY, Oct. 29, 2024 -- Middle-aged folks facing a colon cancer screening now have a blood test they can choose over a standard colonoscopy. However, the...
FDA Approves Orlynvah (sulopenem etzadroxil and probenecid) for the Treatment of Uncomplicated Urinary Tract Infections
DUBLIN and CHICAGO, Oct. 25, 2024 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (Iterum), today announced that the U.S. Food and Drug...
Camurus Provides Regulatory Update on the US NDA for CAM2029 in Acromegaly
Lund, Sweden — 22 October 2024 — Camurus (NASDAQ STO: CAMX) today announced that the U.S. Food and Drug Administration (FDA) has issued a complete...
U.S. FDA Approves Pfizer’s RSV Vaccine Abrysvo for Adults Aged 18 to 59 at Increased Risk for Disease
NEW YORK--(BUSINESS WIRE) October 22, 2024 -- Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved Abrysvo...
Alvotech and Teva Announce U.S. FDA Approval of Additional Presentation of Selarsdi (ustekinumab-aekn), Expanding its Label to Include Further Indications Approved for Reference Product, Stelara (ustekinumab)
REYKJAVIK, Iceland & PARSIPPANY, N.J., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO) and Teva Pharmaceuticals, a U.S. affiliate of Teva...
FDA Approves Vyloy (zolbetuximab-clzb) for the Treatment of Advanced Gastric and GEJ Cancer
TOKYO, Oct. 18, 2024 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that the U.S. Food and Drug...
Botox Cosmetic (onabotulinumtoxinA) Receives FDA Approval for Moderate to Severe Vertical Bands Connecting the Jaw and Neck (Platysma Bands)
IRVINE, Calif., Oct. 18, 2024 /PRNewswire/ -- Today, Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced the U.S. FDA approval of Botox Cosmetic for...
Tonix Pharmaceuticals Announces Submission of the TNX-102 SL New Drug Application (NDA) for Fibromyalgia to the U.S. Food and Drug Administration (FDA)
CHATHAM, N.J., Oct. 16, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), today announced the submission of a...
Stealth BioTherapeutics Announces Positive Vote from FDA Advisory Committee Meeting Supporting Potential Approval of Elamipretide for the Treatment of Barth Syndrome
NEEDHAM, Mass., Oct. 11, 2024 /PRNewswire/ — Stealth BioTherapeutics Inc. (the “Company” or “Stealth”), a clinical-stage...
U.S. Food and Drug Administration (FDA) Accepts New Drug Application for Elinzanetant
Berlin, October 9, 2024 – Bayer today announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s New Drug Application...
Nektar Announces Publication in Nature Communications of Results from Phase 1b Studies of Rezpegaldesleukin in Two Inflammatory Skin Diseases
SAN FRANCISCO, Oct. 29, 2024. Nektar Therapeutics today announced the publication of peer-reviewed data from two Phase 1b studies in Nature Communications...
Merck and Moderna Initiate Phase 3 Trial Evaluating Adjuvant V940 (mRNA-4157) in Combination with Keytruda (pembrolizumab) After Neoadjuvant Keytruda and Chemotherapy in Patients With Certain Types of Non-Small Cell Lung Cancer (NSCLC)
RAHWAY, N.J. & CAMBRIDGE, Mass.--(BUSINESS WIRE) October 28, 2024 -- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and...
Orexo initiates new study of OX640 in participants with allergic rhiniti
UPPSALA, Sweden, Oct. 25, 2024. Orexo AB, today announces the first participants have been dosed with OX640, an intranasal rescue medication for severe...
FDA Grants Rare Pediatric Disease Designation to Omeros’ MASP-3 Inhibitor Zaltenibart for Treatment of C3 Glomerulopathy
SEATTLE--(BUSINESS WIRE)--Oct. 24, 2024-- Omeros Corporation today announced that zaltenibart (OMS906) has received rare pediatric disease designation from the...
NIH Clinical Trial Will Test Precision Medicine Treatments for Myeloid Cancers
Wednesday, October 23, 2024 -- The National Institutes of Health (NIH) has launched a proof-of-concept precision medicine clinical trial to test new treatment...
Browse by news type
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Clinical Trial Results
- Generic Drug Approvals
- Drug Shortages
Drugs.com Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
Disclaimer
This library contains syndicated news articles. These articles have not been peer-reviewed by Drugs.com, and therefore we cannot guarantee accuracy to the highest ethical standards. Do further research as needed. Consultation with your physician is essential.